SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Omeros
OMER 7.330-2.5%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ghmm who wrote (426)7/6/2017 4:21:00 PM
From: rkrw1 Recommendation

Recommended By
Biotech Jim

  Read Replies (1) of 464
 
He?
Art Doyle as in Sir Arthur Doyle?
I assume it could be some hedge fund that is short.

I actually think to be fair they do make some good points, and other places make negative inferences where there may be nothing, and quite low brow insulting OMER investors as being idiots more or less :)

Was it disclosed prior to the report and Omeros update that '721 was i.v. initially and then daily injection for example? Have to credit Art with that disclosure if not.

I'm also curious about the $4.1m settlement with a former CFO Art claims was hidden. It seems very unlikely auditors wouldn't put it into a 10K.

OMER corporate governance could use a boost, such as the CEO's brother being on the board since 1995. But I suppose that could be even worse.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News